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Abstract 
 
 
 
The completion of the genome sequence of Mycobacterium tuberculosis strain H37Rv revealed that 
10% of the coding capacity is devoted to two, large multigene families that are characterised by 
repeat sequences. These are the PE and PPE families that code for acidic, glycine rich proteins. A 
subgroup of the PE family is the polymorphic GC rich sequence (PGRS) gene subfamily. Genome 
comparisons of clinical isolates of M. tuberculosis have confirmed the polymorphic character of some 
of these genes suggesting they may be analogous to the contingency loci found in other pathogenic 
bacteria. Certain PE-PGRS proteins play a direct role in virulence in M. marinum, other PE-PGRS genes 
are cell surface associated, and some PE-PGRS proteins are variable surface antigens, supporting a 
potential role in host pathogen interactions. A reporter assay designed to investigate mutations in a 
PE-PGRS repeat-containing sequence was used to assess mutation rates in various M. smegmatis host 
strains by fluctuation analysis. A wide spectrum of mutations was observed and the evidence suggests 
that slipped-strand mispairing between proximal and distal PGRS sequences located in cis is the 
predominant type of mutational event at such loci. Moreover, slipped-strand mispairing at such loci 
occurs at a moderately higher rate than base substitution mutagenesis and is mediated by the normal 
replicative polymerase.  
 iv 
Acknowledgements 
 
 
 
 
There are many people who helped me during my MSc and I would like to acknowledge all of their 
individual contributions. 
 
To my supervisor, Professor Valerie Mizrahi, thank you for all your input on my project, for your 
constructive criticism and for teaching me so much more than just science.  
 
To my co-supervisor, Dr. Edith Machowski, thank you for all your guidance, for answering my endless 
questions, for your patience and kindness and for always being so bubbly and enthusiastic. I really 
appreciate all that you shared with me. 
 
To my other office colleagues, Digby Warner and Limenako Matsoso, thank you for answering my 
unending questions, for explaining things more than once, for making me laugh and for putting up 
with the Lab Oinker. 
 
To Dr. Bavesh Kana, Dr. Bhavna Gordhan and Dr. Stephanie Dawes, thank you for teaching me how 
to be competent in pouring gels (Bavesh), work in the TB lab (Bhav) and for all the Q and D’s (Steph). 
Thanks too for the great chats, for making me laugh and for letting me act like a monkey. 
 
To Sinah, Julia and Leah, thank you for making life easier. I was very spoilt to have the three of you 
and really appreciate all your hard work. 
 
To my friend Robyn Brackin, thank you for the hours we spent chatting, for the tea and the moans 
and the support. You brought the fun. 
 
To Dr. Marco Weinberg, thank you for all your constructive criticism regarding the first drafts of my 
write-up. You really gave of your time and I truly appreciate it.  
 
To my mom and dad, thank you for all the support and the encouragement and for being interested 
when you had no clue what I was studying. Your guidance and support are priceless. 
 
To my brother, C, thank you for helping with the stress, for making me laugh and for always 
reminding me of the big picture.  
 
To my other folks, Bev and Graham, thank you for all the support, love and the endless chats. I really 
appreciate your time and for being there whenever I needed advice.  
 
To my babe, Liam, thank you for the tickles, for the coffee and the hugs, thank you for the help 
whenever I was stuck or ready to leave, thank you for all that you are and remember that I 
appreciate you every day.  
 
Thanks are also extended to Dr. Stephen Durbach for starting the ball rolling, for making plasmids 
9/19 and pMorf2 and for the lab books – they were a challenge. 
 
To anyone I have not mentioned, please just remember that you all helped in some way and I 
appreciate you.   
 
 
 
 
 
 
 v 
List of Figures 
 
 
Page 
 
Figure 1: The mycobacterial cell envelope. The plasma membrane is composed of a phospholipid bilayer 
with integral proteins. The periplasmic space contains the peptidoglycan and arabinogalactan (indicated 
by orange chain) with long chain mycolic acids covalently bound to the latter polymers. The outer 
capsule-like coat is composed mostly of polysaccharides. PE-PGRS proteins that are localised at the cell 
surface are possibly bound to the peptidoglycan layer allowing them to interact with the extracellular 
milieu............................................................................................................................................... 8 
 
Figure 2: Chromosomal organisation of the conserved loci of dinX and dinP in M. smegmatis as well as a 
third homologous umuC-like gene, dinP3. The genes are indicated by dark red arrows with the gene 
numbers as annotated by TIGR (http://www.tigr.org) indicated at the bottom of the figure. These genes 
encode putative DNA polymerases belonging to the UmuC-DinB-Rad30-Rev1 or Y family of polymerases. 
The green arrows indicate other annotated genes in the M. smegmatis genome. The blue arrows indicate 
genes in M. smegmatis with homology to annotated genes from M. tuberculosis.................................. 12 
 
Figure 3: Members of the PE and PPE protein families. (A) The two main groups within the PE family of 
which the PE-PGRS proteins are the most abundant. Both groups share a common N-terminal domain 
sequence comprised of ~110 amino acids (indicated by orange blocks). The C-terminal domains are 
divergent and range in length from 1 to > 1400 amino acids (indicated by green blocks). The PE-PGRS 
proteins have a common amino acid sequence, GGAGG, repeated in tandem. (B) The three main groups 
within the PPE family. All three groups share a common N-terminal domain composed of ~180 amino 
acids (indicated by purple blocks). The C-terminal domains are divergent and range in length from 1 to > 
3500 amino acids (indicated by yellow blocks). The PPE-MPTR proteins have a repeat sequence 
NXGXGNXG where X can be any amino acid...................................................................................... 15 
 
Figure 4: Sequence variation that exists between M. tuberculosis H37Rv and M. bovis BCG in the PE-
PGRS gene Rv0746. (A) The BCG protein has a deletion of 29 amino acids (indicated by blue arrow) and 
an insertion of 46 amino acids (indicated by pink arrow) compared to the sequence in the M. tuberculosis 
H37Rv counterpart. (B) Specific amino acid sequence variation between H37Rv (upper line of sequence) 
and BCG (lower line of sequence) in gene Rv0746. The 29 amino acid deletion in BCG is indicated by blue 
 vi 
letters. The 46 amino acid insertion in BCG is indicated by pink letters. The Morf2 substrate used in this 
study was based on the 29 amino acid deletion between the 2 sequences (refer to Section 2.10.1)...... 17 
 
Figure 5: Organisation of an opa gene showing the control mechanism of gene expression. The pink 
arrow indicates the functional promoter, part of each unique opa gene. The orange block indicates the 
ATG start codon of the opa gene. The blue block indicates the repeat region of the gene containing 
various numbers of the CTCTT repeat unit (coloured pink or black). Together with the ATG start codon, 
the repeat region forms the hydrophobic signal sequence. The green block indicates the downstream 
portion of the opa gene. The number of CTCTT repeat units within the repeat region affects the open 
reading frame of the opa gene: if the reading frame is incorrect (for example 5 or 6 CTCTT units are 
present), no Opa protein is produced. If the repeat units are in frame (for example 7 CTCTT units) a 
functional Opa protein will be translated. Alterations in the reading frame between the CTCTT repeats are 
RecA independent and hypothesized to be due to replication error...................................................... 23 
 
Figure 6: RecA independent misalignment events involving repeat sequences. (A) Deletion misalignment 
events are formed when there is backward slippage between repeat sequences (indicated by red blocks). 
After replication of the slippage intermediate, one repeat and the intervening DNA sequence (indicated by 
green line) are deleted. (B) Duplication misalignment events are formed when there is forward slippage 
between the repeat sequences. Replication of this slippage intermediate produces an expanded number of 
repeats including a duplication of the intervening sequence................................................................ 25  
 
Figure 7: Schematic diagrams indicating the differences between the Mutation Hypothesis (A and B) and 
the Acquired Immunity Hypothesis (C and D) tested by Luria and Delbrück. (A) According to the Mutation 
Hypothesis, resistant bacteria will occur as a group of closely related individuals as each mutant gives rise 
to clonal progeny. Furthermore if resistance is due to random genetic events occurring prior to the onset 
of a selective pressure, the number of resistant cells within a bacterial population will increase over time 
(B) because the existing mutants grow and divide while new mutants are also added to the resistance 
pool. Alternately, the Acquired Immunity Hypothesis states that cells which mutate to survive the selective 
pressure do so at random under the selective conditions. Their descendants may not do so and their 
subsequent resistance distributions will also be random (C). In addition, if resistance mutations are 
acquired only once a selective pressure is present, the number of resistant cells within a population will 
remain constant over time (D). This is because each cell has a small, constant and independent 
probability of sustaining a resistance mutation prior to selection within its lifetime. For simplicity, each cell 
in Figure 7C only gives rise to a single progeny. Resistant bacteria are indicated by green circles while 
non-resistant bacteria are indicated by purple circles......................................................................... 27 
 
 vii 
Figure 8: Design of KmR based reporter, pGRAK that integrates at the attB locus of M. smegmatis mc2 
155 strains. The RAK fragment is defined by a XbaI site at the 5’ end and an Asp718 site at the 3’ end. 
The pink arrow indicates the Antigen 85A promoter (Ag85A) with ribosome binding site (RBS) and ATG 
start codon. The Morf2 region is defined by a BamHI site at the 5’ end and a NheI site at the 3’ end. This 
region is comprised of three PE-PGRS repeat sequences, called R1 (green block), R3 (yellow block) and 
R2 (blue block) respectively, and an engineered TAG stop codon (red star) in the intervening sequence 
(grey block) between R1 and R3. The 3’ end of the Morf2 region is fused in frame to a cryptic KmR 
cassette (‘aph) indicated by the bright green arrow. A closer look at the DNA sequence making up the 
Morf2 region indicates that the PE-PGRS repeats, R1, R2 and R3 share an 11 base pair (bp) core repeat 
sequence (indicated by underlining of bases). R1 and R2 share a 15 bp repeat sequence, except for one 
base difference. The red bases and stars indicate the TAG stop codon. The green bases and arrows 
indicate repeat 1 (R1). The yellow bases and arrows indicate repeat 3 (R3). The blue bases and arrows 
indicate repeat 2 (R2)...................................................................................................................... 42 
 
Figure 9: Number of culture tubes (C) versus m, the number of mutational events per culture tube. For 
any m value between 10 and 100, the number of cultures tubes required to achieve a theoretical precision 
of 20% using the Lea-Coulsen Method (LC – shown in light blue) or MSS Maximum Likelihood Method 
(MSS – shown in dark blue) can be determined from the graph. Using either method to generate m, the 
number of cultures tubes required decreases as the m value increases. However, due to the iterative 
nature of the MSS Method, the number of culture tubes required by this method is lower overall.......... 45 
 
Figure 10: The power of the rank of a data set (Equation 17) is plotted against iterative m values to 
generate a 2 tailed curve. The m value that correlates with the maximum Equation 17 value is read from 
the graph and this value is used to generate µ. In the example illustrated, the initial m value is 1.6 while 
the m value that maximises Equation 17 from the graph is 1.4........................................................... 47 
 
Figure 11: Classical representation of the Luria-Delbrück model. The data indicates the relationship 
between the number of mutational events (m) within a tube and the number of KmR CFU’s that were 
scored (r). The relationship between r and Pr is tight, i.e. the R2 value is close to 1 if the Luria-Delbrück 
model is a good representation of the underlying biological events. The slope of the graph indicates the 
time point at which the data was collected. (A) During log phase growth, fewer mutational events lead to 
the observed number of KmR mutants and so the slope of the graph is steep. (B) At saturation phase 
growth, the slope is less steep as more mutational events occurred to give rise to the observed KmR 
mutants.......................................................................................................................................... 49 
 
 viii 
Figure 12: Region of the pGRAK reporter plasmid showing the Morf2 region (between BamHI and NheI 
sites) and downstream cryptic ‘aph cassette (NheI to KpnI) with relevant PCR and sequencing primers. 
ANAF and ANAR are forward and reverse PCR primers respectively that amplify a 282 bp product. MFSF is 
a forward sequencing primer. RK aph is a second reverse PCR primer used in conjunction with ANAF to 
amplify the Morf2 region and the cryptic ‘aph cassette. The red star indicates the TAG stop codon within 
the Morf2 region............................................................................................................................. 51  
 
Figure 13: Mechanism of integration of L5 derived vectors into the M. smegmatis mc2 155 chromosome. 
The attP site on the plasmid (indicated by blue blocks on the closed green circle) lines up with the 
corresponding attB site on the bacterial chromosome (indicated by the purple blocks on the orange line). 
Using the phage integrase enzyme (encoded on the plasmid) the attP and attB sites are recombined, 
generating the attL and attR sites. All genetic material contained within the plasmid is linearised and 
becomes part of the bacterial chromosome. PCR primers (indicated by blue and red arrows) were 
designed to flank the attL and attR regions to ensure correct integration of the pGRAK vector into the    
M. smegmatis based strains used in this study.................................................................................. 53 
 
Figure 14: Growth parameters of M. smegmatis mc2 155 grown in MADC-Tw. Log CFU / mL versus Time 
(Hours). Data points are averages of two biological replicates assessed in duplicate. Log phase growth, as 
defined by CFU / mL values of Log107 to Log108, was observed between 12 and 20 hours post inoculation. 
Thereafter, stationary phase growth occurred................................................................................... 55 
 
Figure 15: Confirmation of the integrity of the Morf2 region. (A) Restriction digestion of the GmR cassette 
in the pGRAK reporter. Thirty different restriction endonucleases were used to screen the GmR cassette 
from pGRAK. pHINT was digested with the same endonucleases as a control. All restriction digests were 
separated on agarose gels and selected examples are illustrated. From these and other restriction digests 
(data not shown), it was deduced that the GmR cassette contains EcoRV, BglII, SphI, BstBI and NotI 
restriction sites, the first two sites being previously non-annotated. MW λIII: Molecular Weight Marker 
λIII, MW λVI: Molecular Weight Marker λVI, Uncut: uncut control plasmids pGRAK or pHINT.                
(B) Chromatogram data of the Morf2 region within the pGRAK reporter. The top panel indicates a control 
sample of the Morf2 region while the lower panel indicates a sample sequence selected for comparison. 
The 5’ end of the Morf2 region is defined by a BamHI site (G↓GATCC highlighted by blue block) and the 3’ 
end is defined by a NheI site (G↓CTAGC highlighted by pink block). The stop codon (TAG highlighted by 
red block) is present in both sequences as are the direct repeat sequences R1 (highlighted by green 
block), R2 (highlighted by yellow block) and R3 (highlighted by blue block) respectively 
(5’GGCCGGGGCCGG3’)...................................................................................................................... 57  
 
 ix 
Figure 16: PCR products of attL and attR regions of selected pGRAK based strains used in this study. 
Only correct integration events would have yielded the expected PCR product. The left hand gel indicates 
attL PCR products (320 bp) and the right hand gel indicates attR PCR products (282 bp). Lanes 1: 
Molecular Weight Marker λVI, Lanes 2: control PCR product of 282 bp in length, Lanes 3: control PCR 
product of 263 bp in length and Lanes 4: control PCR product of 245 bp in length. Lanes 5 to 10: attL and 
attR PCR products from separate colonies that were picked from Gm5 plates post electroporation......... 58 
 
Figure 17: Growth of mycobacterial cultures with and without Gm based plasmids over a range of 
antibiotic concentrations. (A) Growth of cultures in liquid medium. Wild type M. smegmatis (indicated as 
mc2 in key) did not grow at Gm concentrations higher than 1 µg / mL. pGINTO based cultures grew 
poorly while pGRAK based cultures grew well at Gm concentrations of 2 µg / mL. Neither Gm based 
plasmid facilitated growth in liquid medium at Gm concentrations higher than 2 µg / mL. (B) Growth of 
cultures on solid agar medium. Wild type    M. smegmatis did not grow at Gm concentrations higher than 
0.1 µg / mL. pGINTO based cultures grew poorly at any Gm concentration higher than 0.5 µg / mL. 
pGRAK based cultures grew well at Gm concentrations up to and including 5 µg / mL. At higher 
concentrations, pGRAK did not facilitate growth on solid agar. Poor growth was defined as an increase in 
OD600 values but few countable CFUs when plated on agar (indicated by arbitrary value of 0.5 graphs in A 
and B). Good growth was defined as CFUs of Log107 when plated on agar (indicated by arbitrary value of 
1 on graphs in A and B)................................................................................................................... 60 
 
Figure 18: Cross-resistance between two aminoglycoside antibiotics, Gm and Km. Cultures grown in 
liquid media containing Gm at a concentration of 2 µg / mL developed cross resistance to low Km 
concentrations (indicated by ‘background’ growth on agar plate containing Km10 on left hand side of 
figure). When the same GmR cultures were plated on agar plates containing a higher Km concentration, 
the ‘background’ growth no longer appeared and only discrete KmR CFUs grew (right hand side of figure). 
Sequence analysis of these KmR CFUs revealed various mutations within the Morf2 region of the pGRAK 
reporter to by-pass the TAG stop codon and allow for expression of a functional Aph fusion protein...... 62 
 
Figure 19: Fluctuation in Nt values was dependant on the growth medium used. Ten parallel tubes that 
contained the same culture were grown in three different media that each contained Gm at a 
concentration of 2 µg / mL to maintain the plasmid within the bacteria. (A) Nt values of mc
2 155 (pGRAK) 
cultures grown in general LB media. (B) Nt values of mc
2 155 (pGRAK) cultures grown in enriched 2TY 
media. (C) Nt values of mc
2 155 (pGRAK) cultures grown in mycobacterium-specific MADC-Tw............. 63 
 
Figure 20: Nt values assessed at different time points during growth of mc
2 155 (pGRAK) in MADC-Tw. 
Early log cultures were assessed after 24 hours, mid log cultures after 48 hours and saturation cultures 
 x 
after 114 hours of growth. In each case, Nt values were assessed from the same tube that was then 
cultured further. The Nt values (Log CFU / mL) increased over time from Log106 CFU / mL at early log 
phase to Log109 CFU / mL at saturation phase, however at each time point, the Nt values were 
comparable between tubes.............................................................................................................. 64 
 
Figure 21: Chromatogram data showing the wild type (GAG) Histidine auxotroph (His-) sequence (upper 
panel) and the revertant (GGG) Histidine prototroph (His+) sequence (lower panel) in selected mc2 155 
hisG380E clones. The reversion mutation from GAG to GGG is highlighted by the black box. The base 
substitution mutation results in a codon change from glutamate (E) to glycine (G)............................... 69 
 
Figure 22: Flow diagram outlining the experimental procedures followed to generate µ values and to 
assess the spectrum of mutations per mycobacterial host background. Fluctuation Tests generated a µ 
value and KmR CFU’s. A random selection of these mutants were subsequently subjected to PCR to 
determine the type of mutation that had occurred in the Morf2 region of the pGRAK reporter that led to 
KmR. Between 80 and 300 KmR CFUs per Fluctuation Test were assessed by PCR, depending on the 
number of jackpots that had occurred. Once PCR was complete, a select group of PCR products were 
sequenced to verify the specific genotypic mutation that had occurred................................................ 72 
 
Figure 23: Spectrum of KmR mutations observed in mc2 155 (pGRAK) CFUs as shown by gel 
electrophoresis. Lane 1: Molecular Weight Marker λVI. Lanes 2 to 12: PCR products from separate KmR 
colonies that were picked from a single tube. The PCR products vary in size, indicating a number of 
underlying mutational events........................................................................................................... 73 
 
Figure B1: Plasmids p9/19, pHINT, pGINTO and pGRAK................................................................... 89  
 
Figure B2: Plasmids pOLYGaa, pOLYGaadinP and pOLYGaadinX........................................................ 90 
 
Figure D1: Clumping of mycobacterial cultures. (A) Culture tubes used in Fluctuation Tests were placed 
in a beaker partly filled with water and secured with paper towel. Cultures grown in this manner for 2 or 6 
days (B) did not clump, therefore Nt values assessed from these tubes were reproducible.................... 95  
 
Figure E1: Sequence data of Morf2 region indicating a spectrum of mutations resulting in KmR. G↓GATCC 
at the 5’ end of the sequences indicates the BamHI site at the start of the Morf2 region. G↓CTAGC at the 
3’ end of the sequence indicates the NheI site at the start of the ‘aph cassette. R1 is highlighted by green 
blocks. The TAG stop codon is highlighted by red blocks. R2 and R3 are highlighted by blue and yellow 
blocks respectively. The point mutation within TAG to form a codon encoding Leucine is highlighted by the 
 xi 
bright green block. The point mutation to form an alternative in frame start codon (GTG) is highlighted by 
the orange block. IV = intervening sequence.................................................................................... 96  
 
Figure E2: Sequence data indicating a KmR clone with duplication in the ‘aph cassette. The upper 
sequence indicates the wild type ‘aph cassette from the NheI site at the 3’ end of the Morf2 sequence 
(indicated by pink block at the 5’ end of the sequence). The lower sequence indicates the KmR mutant 
with the duplicated portion of the ‘aph cassette (indicated by the purple blocks) that in turn created a new 
in frame ATG start codon (indicated by the orange block).................................................................. 97 
 
 
 
 
 
 
 
 
 
 
 
 xii 
List of Tables 
 
 
Page 
 
Table 1: Luria and Delbrück’s Fluctuation Test confirming the Mutation Theory of spontaneous mutation. 
The mean is the average number of phage resistant bacteria within a set of parallel cultures. The variance 
is a measure of the fluctuating spread of variables about the mean.................................................... 28 
 
Table 2: M. smegmatis strains used in this study.............................................................................. 34  
 
Table 3: Plasmids used in this study (refer to Appendix B for plasmid maps)...................................... 35 
 
Table 4: Oligonucleotide sequences used for PCR and sequencing..................................................... 50    
 
Table 5: m values, average Nt values and µ values assessed at different time points in various 
mycobacterial strains....................................................................................................................... 67  
 
Table 6: Comparison of mutation frequencies and mutation rates for KmR in mc2 155 (pGRAK)............ 71  
 
Table 7: Spectrum of mutational events in the Morf2 region of the pGRAK reporter as well as mutations 
within the ‘aph cassette that resulted in KmR..................................................................................... 75 
 
Table 8: Relative percentages of three different groups of mutations per pGRAK-based host strain used 
in this study.................................................................................................................................... 77 
 
Table B1: Symbol definitions of the plasmid maps in Appendix B....................................................... 91 
 
Table C1: Specific experimental parameters used for each Fluctuation Test in this study..................... 92 
 xiii 
Glossary 
 
 
 
aph  aminoglycoside phosphotransferase gene that encodes kanamycin resistance 
‘aph  cryptic aph cassette that does not encode its own ATG start codon 
ADC  albumin, dextrose, catalase supplement for MADC-Tw 
Amp  ampicillin antibiotic 
attB attachment site within the bacterial chromosome used during plasmid integration 
attP  phage attachment site within the plasmid that integrates at the bacterial attB site 
BCG  bacille Calmette-Guérin 
bla  gene encoding β-lactamase for ampicillin resistance 
bp  base pairs 
C  number of culture tubes per Fluctuation Test  
CD4+  subgroup of CTLs that form part of the human immune system  
CFU  colony forming unit 
CL  confidence limit 
CTL  cytotoxic T lymphocyte 
dinP  gene encoding DinP error prone polymerase 
dinX  gene encoding DinX error prone polymerase 
dNTP’s  deoxyribonucleotide triphosphates 
DOTS  directly observed treatment, short course 
EBV  Epstein-Barr Virus 
EBNA  Epstein-Barr virus nuclear antigen    
EMB  ethambutol antibiotic 
EP  error-prone 
G  guanine 
Gm  gentamicin antibiotic 
GTP  guanosine triphosphatase 
his D   gene encoding histidine 
His-  histidine auxotrophy 
His+  histidine prototrophy 
HIV  Human Immunodeficiency Virus 
hyg  gene encoding hygromycin B resistance 
Hyg   hygromycin B antibiotic 
IFN-γ  interferon γ 
INH  isoniazid antibiotic 
int  gene encoding phage integrase enzyme 
 xiv 
IV  intervening sequence 
kDa  kilo Dalton 
Km  kanamycin antibiotic 
LA  Luria Bertani Agar 
LB  Luria Bertani Broth 
lacZ   gene encoding β-galactosidase 
µ  mutation rate = probability of mutation per cell per division or generation 
µg  microgram 
µL  microlitre 
m  number of mutational events per culture tube  
MADC-Tw Middlebrook 7H9 broth supplemented with ADC and 0.1% Tween 80 
MDR-TB multi-drug resistant Mycobacterium tuberculosis 
MHC  major histocompatibility complex  
MIC  minimal inhibitory concentration of drug used to prevent growth of a pathogen 
Morf2  reporter construct containing 3 repeat elements and engineered stop codon  
MMR  mismatch repair 
MPTR  major polymorphic tandem repeats 
MSP-1  major surface protein 1 antigen located on Aniplasma marginale 
MSS  Ma-Sandri-Sarkar Maximum Likelihood Method for calculating µ 
No  initial population numbers within a single fluctuation assay tubes 
Nt  final population numbers within a single fluctuation assay tubes 
NO   nitric oxide 
NOS2  nitric oxide synthase 
OADC  oxalic acid, albumin, dextrose, catalase supplement for Middlebrook 7H10 agar 
OD600  optical density at 600 nm 
Opa  opacity proteins expressed on the surface of Neisseria gonorrhoeae  
OriM  origin of replication used in Mycobacterium smegmatis plasmids 
PE  proline glutamate  
PGRS  polymorphic GC rich repetitive sequence 
PknG  protein kinase G 
Po   distribution of culture tubes yielding no mutants 
POA  pyrazinoic acid  
PPE  proline proline glutamate  
PZA  pyrazinamide antibiotic 
r  observed number of mutants scored per selective plate 
R  resistant 
RAK  Repeat Aminoglycoside phosphotransferase Kanamycin 
RBS  ribosome binding site 
 xv 
RecA  protein involved in DNA recombination events 
RFLP  restriction fragment length polymorphism 
Rif  rifampicin antibiotic 
RNI’s  reactive nitrogen intermediates 
ROI’s  reactive oxygen intermediates 
rpm  revolutions per minute 
S  sensitive 
Str  streptomycin antibiotic 
TB  tuberculosis 
Tw  Tween 80 
U  unit 
Vaa  variable adherence associated proteins found on Mycoplasma hominis 
